The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Self assessment of buccodental toxicity: Comparison of patients with metastatic renal cell carcinoma (RCC) treated with sunitinib with patients treated with chemotherapy.
M. Gilabert
No relevant relationships to disclose
M. Provansal
No relevant relationships to disclose
M. Cappiello
No relevant relationships to disclose
J. Walz
No relevant relationships to disclose
S. Brunelle
No relevant relationships to disclose
N. Salem
No relevant relationships to disclose
G. Gravis
No relevant relationships to disclose